Mitochondrial toxicity in HIV type-1-exposed pregnancies in the era of highly active antiretroviral therapy
- 1 April 2008
- journal article
- Published by SAGE Publications in Antiviral Therapy
- Vol. 14 (3) , 331-338
Abstract
Background: The aim of this study was to determine the effects of HIV type-1 (HIV-1) infection and antiretroviral therapy (ART) on placental mitochondria. Methods: HIV-1-infected pregnant women and HIV-1 -uninfected controls were enrolled prospectively. Placental mitochondrial DNA (mtDNA) copy numbers were determined by quantitative PCR, subunits II and IV of cytochrome c oxidase (COX) were quantified by western blot and mitochondrial ultrastructure was evaluated by electron microscopy. Venous blood lactate was measured in newborns. Results: In total, 45 HIV-1-infected pregnant women on ART and 32 controls were included. Mean ±sd mtDNA copy numbers were significantly reduced in ART and HIV-1-exposed placentas (240 ±118 copies/ cell) in comparison with controls (686 ±842 copies/cell; P<0.001). The mean COX II/IV ratio was 48% lower in the investigational group compared with controls ( P<0.001). There was no evidence of severe ultrastructural damage within mitochondria of HIV-1-infected ART-exposed placentas. Although lactate levels between newborns did not differ, they were negatively correlated with placental mtDNA levels. There was no clear association between mitochondrial parameters and a particular nucleoside reverse transcriptase inhibitor (NRTI), the number of NRTIs or time of NRTI exposure. Conclusions: Placental tissue of HIV-1-infected ART-exposed pregnancies shows evidence of mtDNA depletion with secondary respiratory chain compromise. The clinical effects of this finding warrant further investigation.Keywords
This publication has 24 references indexed in Scilit:
- Increased mtDNA Levels Without Change in Mitochondrial Enzymes in Peripheral Blood Mononuclear Cells of Infants Born to HIV-Infected Mothers on Antiretroviral TherapyHIV Research & Clinical Practice, 2008
- Clinical mitochondrial dysfunction in uninfected children born to HIV‐infected mothers following perinatal exposure to nucleoside analoguesEnvironmental and Molecular Mutagenesis, 2007
- Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor‐induced mitochondrial toxicityEnvironmental and Molecular Mutagenesis, 2007
- Uridine supplementation antagonizes zalcitabine-induced microvesicular steatohepatitis in miceHepatology, 2006
- Mitochondrial disease in the offspring as a result of antiretroviral therapyExpert Opinion on Drug Safety, 2006
- Maternal smoking is associated with mitochondrial DNA depletion and respiratory chain complex III deficiency in placentaAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Hyperlactatemia in Human Immunodeficiency Virus–Uninfected Infants Who Are Exposed to AntiretroviralsPediatrics, 2004
- Mitochondrial Damage Revealed by Morphometric and Semiquantitative Analysis of Mouse Pup Cardiomyocytes Following in Utero and Postnatal Exposure to Zidovudine and LamivudineToxicological Sciences, 2004
- Mitochondrial Toxicity in Fetal Erythrocebus patas Monkeys Exposed Transplacentally to Zidovudine Plus LamivudineAIDS Research and Human Retroviruses, 2004
- An mtDNA Mutation in the Initiation Codon of the Cytochrome C Oxidase Subunit II Gene Results in Lower Levels of the Protein and a Mitochondrial EncephalomyopathyThe American Journal of Human Genetics, 1999